Myra E. van Linde
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Co-authors
- Lukas J.A. Stalpers (3 shared papers)Wouter R. van Furth (3 shared papers)D. J. Richel (3 shared papers)Joost J.C. Verhoeff (3 shared papers)Henk M.W. Verheul (17 shared papers)Jaap C. Reijneveld (6 shared papers)Olaf van Tellingen (1 shared paper)William P. J. Leenders (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (3 papers)Journal of Cancer Survivorship (2 papers)Journal of Neuro-Oncology (2 papers)The Oncologist (2 papers)
- Partner nations
- NetherlandsUnited StatesAustralia
In The Last Decade
Myra E. van Linde
31 papers receiving 696 citations
Peers
Comparison fields: 5 of 80
- Genetics 365
- Cancer Research 154
- Oncology 188
- Pulmonary and Respiratory Medicine 157
- Radiology, Nuclear Medicine and Imaging 107
Countries citing papers authored by Myra E. van Linde
This map shows the geographic impact of Myra E. van Linde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myra E. van Linde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myra E. van Linde more than expected).
Fields of papers citing papers by Myra E. van Linde
This network shows the impact of papers produced by Myra E. van Linde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myra E. van Linde. The network helps show where Myra E. van Linde may publish in the future.
Co-authors
The 25 scholars most cited alongside Myra E. van Linde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 146 | |
| 2 | 2017 | 143 | |
| 3 | 2017 | 71 | |
| 4 | 2010 | 71 | |
| 5 | 2020 | 43 | |
| 6 | 2021 | 24 | |
| 7 | 2014 | 23 | |
| 8 | 2020 | 22 | |
| 9 | 2019 | 19 | |
| 10 | 2015 | 18 | |
| 11 | 2022 | 17 | |
| 12 | 2015 | 15 | |
| 13 | 2021 | 14 | |
| 14 | 2016 | 14 | |
| 15 | 2019 | 11 | |
| 16 | 2020 | 11 | |
| 17 | 2019 | 9 | |
| 18 | 2024 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2022 | 5 |
About Myra E. van Linde
Myra E. van Linde is a scholar working on Genetics, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 34 papers that have together received 719 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (18 papers), Cancer survivorship and care (7 papers), Brain Metastases and Treatment (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Meningioma and schwannoma management (3 papers), Palliative Care and End-of-Life Issues (3 papers) and Patient-Provider Communication in Healthcare (2 papers). The work is most often cited by research in Genetics (365 citations), Cancer Research (154 citations), Oncology (188 citations), Pulmonary and Respiratory Medicine (157 citations) and Radiology, Nuclear Medicine and Imaging (107 citations). Myra E. van Linde has collaborated with scholars based in Netherlands, United States and Australia. Frequent co-authors include Lukas J.A. Stalpers, Wouter R. van Furth, D. J. Richel, Joost J.C. Verhoeff, Henk M.W. Verheul, Jaap C. Reijneveld, Olaf van Tellingen, William P. J. Leenders, Roelien H. Enting and Annemiek Walenkamp. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Cancer Survivorship, Journal of Neuro-Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.